Skip to main content
. 2022 Nov 6;14(11):2394. doi: 10.3390/pharmaceutics14112394

Figure 7.

Figure 7

Phase-contrast photomicrographs of the “zero wound” (control) and wounds of (A) 4T1, (B) MDA-MB-231, (C) MCF-7 cell lines, exposed to 500 nM of DOX(free or encapsulated into LPNP), for 24 h at 37 °C. Amplification 5×.